A Cannabigerol Derivative Suppresses Immune Responses And Protects Mice From Experimental Autoimmune Encephalomyelitis

Encephalomyelitis

Key Findings

This study highlights the therapeutic potential of VCE-003 as an agent for the treatment of human immune diseases with both inflammatory and autoimmune components.

Information and Links


Link: A Cannabigerol Derivative Suppresses Immune Responses And Protects Mice From Experimental Autoimmune Encephalomyelitis

Year: 2014

DOI: 10.1371/journal.pone.0094733


Ratings

(How Ratings Work)

Encephalomyelitis — 1


Possibility of efficacy for cannabis in treatment of Encephalomyelitis according to the results found in this study.

Drugs Used

A cannabigerol quinone (VCE-003)